GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VivoSim Labs Inc (FRA:4OR) » Definitions » Additional Paid-In Capital

VivoSim Labs (FRA:4OR) Additional Paid-In Capital : €333.64 Mil(As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is VivoSim Labs Additional Paid-In Capital?


VivoSim Labs's quarterly additional paid-in capital declined from Jun. 2024 (€324.84 Mil) to Sep. 2024 (€314.65 Mil) but then increased from Sep. 2024 (€314.65 Mil) to Dec. 2024 (€333.64 Mil).

VivoSim Labs's annual additional paid-in capital increased from Mar. 2022 (€306.85 Mil) to Mar. 2023 (€317.86 Mil) but then declined from Mar. 2023 (€317.86 Mil) to Mar. 2024 (€315.80 Mil).


VivoSim Labs Additional Paid-In Capital Historical Data

The historical data trend for VivoSim Labs's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VivoSim Labs Additional Paid-In Capital Chart

VivoSim Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 277.01 281.80 306.85 317.86 315.80

VivoSim Labs Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 314.34 315.80 324.84 314.65 333.64

VivoSim Labs Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

VivoSim Labs Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of VivoSim Labs's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


VivoSim Labs Business Description

Traded in Other Exchanges
Address
11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

VivoSim Labs Headlines

No Headlines